1
1
20
20
2
2
1
1
2
2
1
1
7
7
5
5
2020
2012
Research Institution (219)University (6)
1 - 10 of 219
Sort by
Publication
ID32327249Published Date2020-04-20JournalThe Veterinary clinics of North America. Food animal practice, 2020-04-20
Mycoplasma bovis is an important component of the bovine respiratory disease complex and recent reports identified that other species are also affected by M bovis. Control of the disease caused by M bovis has been unsuccessful owing to many factors, including the capacity of M bovis to evade and modulate the immune system of the host; the lack of known virulence factors; the absence of a cell wall, which renders antibiotics targeting cell-wall synthesis unusable; and the failure of vaccines t…
Web Document
Date Added2020-05-02
Vaccine and Infectious Disease Organization - International Vaccine Centre SOLUTIONS T H R O U G H R E S E A R C H A FULL RANGE OF SERVICES • Study design • Animal model development including surgical models • Host-pathogen interaction studies • Pre-clinical studies for human vaccines, antivirals and therapeutics • Full regulatory studies for veterinary vaccines, antivirals and therapeutics • In vitro antiviral assays including virus neutralization • Serial release testing for veterinary vacc…
Publication
ID32121117Published Date2020-02-28JournalViruses, 2020-02-28, Volume 12
The constant crosstalk between the large avian reservoir of influenza A viruses (IAV) and its mammalian hosts drives viral evolution and facilitates their host switching. Direct adaptation of an avian strain to human or reassortment between avian-origin gene segments with that of human strains are the two mechanisms for the emergence of pandemic viruses. While it was suggested that the 1918 pandemic virus is of avian origin, reassortment of 1918 human isolates and avian influenza viruses led …
Web Document
Date Added2020-05-08
VIDO-InterVac Annual Report 2018–2019 2 V ID O -I N T E R V A C A n n u al R ep o rt 2 01 8– 2 01 9 1 Contents 3 Vision and Mission 4 Message from the Chair 5 Board of Directors 6 Message from the Director & CEO 9 Human and Animal Health Research Highlights 14 Vaccine Discovery Pipeline Highlights 16 Dr. Andrew Potter: A Career in Reflection 18 Facility Highlights 20 Financial Highlights 21 2018–2019 Community Liaison Committee Report“Recent epidemics of high-risk pathogens demonstrate the im…
Publication
ID32088679Published Date2020-01-31JournalJournal of infection in developing countries, 2020-01-31, Volume 14
On 31 December 2019 the Wuhan Health Commission reported a cluster of atypical pneumonia cases that was linked to a wet market in the city of Wuhan, China. The first patients began experiencing symptoms of illness in mid-December 2019. Clinical isolates were found to contain a novel coronavirus with similarity to bat coronaviruses. As of 28 January 2020, there are in excess of 4,500 laboratory-confirmed cases, with > 100 known deaths. As with the SARS-CoV, infections in children appear to be …
Web Document
Date Added2020-05-02
For more information contact: PAUL HODGSON Associate Director - Business Development 306-966-7465 contracts@vido.org Vaccine and Infectious Disease Organization - International Vaccine Centre / Example Disease Models ** CL3 CL2 * Risk group 2+ working in level 3 containment, ** Cotton rat, rat and mouse, *** Serotypes B and E Models currently in development Chronic wasting disease* Influenza Middle East respiratory syndrome Mycobacterium tuberculosis/bovis Pasteurella multocida*** Actinobacil…
Web Document
Date Added2020-05-02
Vaccine and Infectious Disease Organization - International Vaccine Centre For more information contact: PAUL HODGSON Associate Director - Business Development 306-966-7465 contracts@vido.org 45+ PhD level scientists Scientists from 25+ countries 8 commercialized vaccines...6 world firstsLOCATED IN Saskatchewan, Canada 150 infectious disease & vaccine studies conducted annually >$200M in biocontainment infrastructure Certified to www.vido.org ISO 9001 SOLUTIONS T H R O U G H R E S E A R C H A…
Publication
ID30909866Published Date2019-03-25JournalBMC microbiology, 2019-03-25, Volume 19
Neisseria gonorrhoeae is an obligate human pathogen and its adherence to host cells is essential for its pathogenesis. Gonococcal adherence assays are based on the enumeration of bacteria attached to human cells on solid media. Because conventional adherence assays are based on bacterial counts, they are often time consuming to perform and prone to observer bias. A flow cytometry based method, using the cell-permeable fluorescent dye 5'-carboxyfluoroscein succidyl ester (CFSE), was developed …
Web Document
Date Added2020-05-02
Vaccine and Infectious Disease Organization - International Vaccine Centre For more information contact: PAUL HODGSON Associate Director - Business Development 306-966-7465 contracts@vido.org 45+ PhD level scientists Scientists from 25+ countries 8 commercialized vaccines...6 world firstsLOCATED IN Saskatchewan, Canada 150 infectious disease & vaccine studies conducted annually >$200M in biocontainment infrastructure Certified to www.vido.org ISO 9001 SOLUTIONS T H R O U G H R E S E A R C H A…
Web Document
Date Added2020-05-02
20 15 -2 01 6 V ID O- IN TE RV AC A NN UA L R EP OR T TABLE OF CONTENTS COMMITMENT TO LEADERSHIP AND INNOVATION Leonard Edwards – Board Chair THE CHANGING NATURE OF INFECTIOUS DISEASES Andrew Potter – Director and CEO MEETING CHALLENGES AT THE HUMAN-ANIMAL INTERFACE Volker Gerdts – Associate Director of Research ENHANCING OUR GLOBAL IMPACT Paul Hodgson – Associate Director of Business Development CONNECTING PEOPLE TO COMBAT EMERGING DISEASES Joyce Sander – Associate Director of Human Resource…
We found 219 documents that match your Search
Publications: 8
Web Documents: 211

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in